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Background: Hygiene behavior plays a relevant role in infectious disease transmission. The aim of this study was to
evaluate non-pharmaceutical interventions (NPI) in preventing pediatric influenza infections.
Methods: Laboratory confirmed influenza cases occurred during 2009–10 and 2010–11 seasons matched by age
and date of consultation. NPI (frequency of hand washing, alcohol-based hand sanitizer use and hand washing after
touching contaminated surfaces) during seven days prior to onset of symptoms were obtained from parents of
cases and controls.
Results: Cases presented higher prevalence of underlying conditions such as pneumonia [OR = 3.23;
95 % CI: 1.38 – 7.58 p = 0.007], asthma [OR = 2.45; 95 % CI: 1.17 – 5.14 p = 0.02] and having more than 1 risk
factor [OR = 1.67; 95 % CI: 0.99 – 2.82 p = 0.05]. Hand washing more than 5 times per day [aOR = 0.62; 95 % CI: 0.39 –
0.99 p = 0.04] was the only statistically significant protective factor. When considering two age groups (pre-school age
0–4 yrs and school age 5–17) yrs , only the school age group showed a negative association for influenza infection for
both washing more than 5 times per day [aOR = 0.47; 95 % CI: 0.22 – 0.99 p = 0.04] and hand washing after touching
contaminated surfaces [aOR = 0.19; 95 % CI: 0.04 – 0.86 p = 0.03].
Conclusion: Frequent hand washing should be recommended to prevent influenza infection in the community
setting and in special in the school age group.
Keywords: Influenza, Child, Non-pharmaceutical measures, Hand hygiene, Community setting, Prevention, Case control
studyBackground
The community setting and hygiene behavior play an
important role in controlling influenza, whether seasonal
or pandemic, and emerging infectious diseases provide a
good chance for promoting universal preventive mea-
sures such as hand hygiene [1]. The World Health
Organization (WHO) and other health organizations
have stressed the need to highlight the importance of
non-pharmaceutical interventions (NPI) such as hand* Correspondence: nuria.torner@gencat.cat
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vent influenza transmission in the community [2, 3]. Never-
theless, because some NPI measures are readily available and
applicable for the general population they can be routinely
instituted during influenza season regardless of pandemic
threat evidence [4–7]. Household transmission of influenza
can be reduced by the use of NPI, but low acceptability of
some NPI such as facemasks make it more difficult to
comply with some of these recommendations.
Hand hygiene is a key intervention for reducing trans-
mission of acute respiratory infections (ARI) and other
infections such as diarrhea in community settings. Hand
hygiene has been specifically recommended for preven-
tion of diseases with pandemic potential, such as severe
acute respiratory syndrome and for pandemic influenzaticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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in hand hygiene resulted in reductions in respiratory
illness by 21 %, hand-hygiene education with use of
non-antibacterial soap, being the most beneficial
intervention [7].
Yet studies examining hygiene practices during re-
spiratory illness and interventions targeting aerosol
transmission are needed [8]. It has been postulated that
the effect of interventions may be higher in the pan-
demic scenario because of public anxiety giving way to
higher rates of adherence, similar to what was observed
during the SARS epidemic [9].
During 2009 influenza pandemic there was some un-
certainty as to which NPI to recommend, especially
whether facemasks should be endorsed [10].
The aim of the study was to investigate the effective-
ness of non-pharmaceutical interventions in preventing
cases of influenza in children in the community setting
in 2009 pandemic and 2010–2011 post-pandemic/seasonal
epidemic.
Methods
A multicenter matched case–control study was per-
formed in 7 regions of Spain from July 2009 to May
2011, with controls matched for age, hospital and date
of hospitalization. For each confirmed hospitalized case
of pandemic influenza, 1 confirmed outpatient case and
3 controls (2 hospitalized and 1 outpatient) were se-
lected. Demographic variables, underlying medical con-
ditions, use of antiviral agents, vaccines received and
hygiene habits were collected for all cases and controls.
The confirmed outpatient cases were obtained from the
sentinel primary care Influenza surveillance network; of
these only confirmed pediatric cases and controls
which had been previously selected to match hospital-
ized influenza confirmed cases recruited for the multi-
center case control study were used in this study [11].
All participating centers were granted approval by
their ethics committees to carry out the study, namely
the following: Comité Etico de Investigación Clínica de
Euskadi; Comité Etico de Investigación Clínica Hospital
Universitario Dr. Peset (Valencia); Comité Etico de
Investigación Clínica Hospital Costa del Sol_Marbella
(Màlaga); Comité Etico de Investigación Clínica Hospital
Universitari Sant Joan de Déu de Esplugues (Barcelona);
Comité Etico de Investigación Clínica Instituto Municipal
de Asistencia Sanitaria_IMAS (Barcelona); Comité
Etico de Investigación Clínica Dirección General de
Salud Pública y Centro Superior de Investigación en
Salud Pública (Madrid); Comité Etico de Investigación
Clínica Comité Autonómico de ensayos clínicos de
Andalucia and Comité Etico de Investigación Clínica
Clínica de León and Corporación Sanitaria Parc Taulí
de Sabadell.Settings
For each of the 7 regions where this study was per-
formed the setting of recruited cases was the primary
care sentinel pediatricians from the influenza surveil-
lance network [12].
Selection of cases and controls
Only Influenza AH1N1pmd09 virus was isolated in both
influenza seasons studied. Pandemic season was consid-
ered from July 2009 to August 2010 when WHO de-
clared the end of pandemic period] and post-pandemic
or seasonal from October 2010 to May 2011. Outpatient
children between 6-months and 17 years old with la-
boratory confirmed influenza and matched controls were
recruited [12].
Size of the sample was calculated for the main study
and the number of pediatric outpatient cases selected
as outpatient controls for a hospitalized case made
up the subset sample for this study on community
based pediatric influenza cases and controls. Patients
with influenza-like-illness (ILI) in whom influenza A
H1N1pdm09 virus infection was confirmed by real
time–polymerase chain reaction (RT-PCR) were selected
from the outpatient Primary Care Influenza Surveillance
Sentinel Network as cases. An outpatient control was
selected from patients attending those same primary
healthcare centers (PHC) consulting for other illness
than ILI or other acute respiratory tract infection (ARI)
Considering ILI symptoms as sudden onset of symp-
toms, fever and at least one of the following: malaise,
headache, muscle pain; and at least one of the following:
cough, sore throat, shortness of breath. Outpatient cases
and controls were matched according to age (±3 years),
geographical area and consultation date allowing for a
range of ±10 days.
Sociodemographic and clinical data
The following demographic variables and pre-existing
medical conditions were collected for all study partici-
pants: age, sex, ethnicity, educational level and smoking
habits of parents risk factors for acquiring influenza [his-
tory of pneumonia in the last two years, asthma, renal
failure, diabetes, disabling neurological disease, neopla-
sia, transplantation, morbid obesity (BMI according to
age) [13], treatment with systemic or inhaled corticoste-
roids, and antibiotic treatment within 90 days prior to
onset of symptoms of the case and influenza (pandemic
and seasonal)], [13]. Children were considered vacci-
nated with the seasonal influenza vaccine if they had
received a dose of the vaccine at least 14 days before the
onset of symptoms (cases] or the date of consultation
for controls. For pandemic influenza vaccine children
were considered vaccinated if they had received the pan-
demic influenza vaccine at least 7 days before the onset
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trols. For the pneumococcal conjugate vaccines, a child
was considered vaccinated if he had received the recom-
mended doses according to age. Cases were considered
vaccinated if they had received the last dose (or only
dose if this was the schedule corresponding to their
age) ≥14 days before symptom onset. Controls were
considered vaccinated if they had received the last
dose (or only dose if this was the schedule corresponding
to their age) ≥14 days the date of consultation of the
matched case. Information on the vaccination status was
obtained from primary healthcare centre registers or vac-
cination cards.
Information on and use of non-pharmaceutical
interventions
A structured interview was used to determine whether
study participants/parents had received information on
preventing the transmission of pandemic influenza. Par-
ticipants (or their parents if they were under 12 years)
were asked about the use of non-pharmaceutical inter-
ventions as yes/no variables (frequent hand washing: 1–
4 times/day >5 times/day, use of alcohol-based hand
sanitizers, hand washing at home after touching poten-
tially contaminated surfaces on public transport or in
shops) and , frequency of public transportation use, and
the use of face masks) seven days before the onset of
symptoms in cases and controls. Frequency was asked
for each variable and then broken down into two
groups.
There were no refusals to participate in the study.
Statistical analysis
A bivariate comparison was made between cases and
controls for demographic variables and pre-existing
medical conditions using Pearson’s Chi-square test for
categorical variables and the Student t test for continu-
ous variables. The crude Odds Ratio (OR) were esti-
mated using the McNemar test.
A multivariate analysis was performed using condi-
tional logistic regression to estimate adjusted OR (aOR),
including age group (0–4 years and 5–17 years) and
non-pharmaceutical interventions. Both seasons with
circulating A H1N1pmd09 virus were also analyzed
separately for the same variables. The analysis was per-
formed using SPSS version 18.
Data confidentiality and ethical aspects
All information collected was treated as confidential in
strict observance of legislation on observational studies.
The study was approved by the Ethics Committees of
the participating hospitals. Written informed consent
was obtained from patients included before interviews
were carried out.Results
A total of 239 cases with confirmed influenza
AH1N1pmd09 virus infection and 239 matched controls
were included. Cases had a mean age of 5.4 years
(SD = ±4.5), 42.3 % were females, 88.9 % were Caucasian,
74.3 % had secondary or higher education, 36.6 % had par-
ents smokers and only 0.9 % had received any influenza
vaccine while 35.9 % had received at least one dose of
pneumococcal vaccine and 32.7 % were fully vaccinated ac-
cording to their age. Controls had similar characteristics
with no significant differences (Table 1).
Cases presented a higher prevalence of underlying con-
ditions such as pneumonia in the previous two years
[OR = 3.23; 95 % CI: 1.38 – 7.58 p = 0.007], asthma
[OR = 2.45; 95 % CI: 1.17 – 5.14 p = 0.02] and pre-
senting more than 1 co morbidity [OR = 1.67; 95 % CI:
0.99 – 2.82 p = 0.05] (Table 1). The frequency of hand
washing > 5 times [aOR = 0.62; 95 % CI: 0.39 – 0.99
p = 0.04] was the only statistically significant protective
factor (Table 2).
Statifying the sample into two age groups (0–4 years
and 5 to 17 years) the only statistically significant risk
factor was having had pneumonia in the previous two
years [OR = 6.00; 95 % CI: 1.34 – 26.81 p = 0.02], was
(Table 3).
The school age group (5–17 years) showed a negative
association for influenza infection for both washing
more than 5 times per day [aOR = 0.47; 95 % CI: 0.22 –
0.99 p = 0.04] where in the 0–4 years group there was
no significant association observed [aOR = 0.91; 95 %
CI: 0.46 – 1.78 p = 0.77] and hand washing after touch-
ing contaminated surfaces [aOR = 0.19; 95 % CI: 0.04 –
0.86 p = 0.03] versus [aOR = 1.06; 95 % CI: 0.44 – 2.56
p = 0.77] in the 0–4 years group (Table 4)].
Stratifying the 0–4 age group into 0–2 years and 3–4
years, no significant differences were observed in cases
and controls with respect to the questions referring to
having received information regarding influenza preven-
tion, frequency of daily hand washing or use of alcohol-
based hand sanitizers or hand washing after touching
potentially contaminated surfaces.
Discussion
In the light of the possibility of other future influenza
pandemics, examining public response to the A
H1N1pmd09 influenza pandemic can provide informa-
tion in terms of willingness to adopt preventive behav-
iors. In a polling study conducted by Steel Fisher et al.
in five countries [14], in all countries the most com-
monly adopted personal protective behavior was to wash
hands or use hand sanitizer more often.
This study highlights the effectiveness of hand washing
in preventing infection due to influenza A H1N1pmd09 in
the pediatric community setting. It has been proven by
Table 1 Distribution of sociodemographic variables and underlying medical conditions for confirmed outpatient cases and controls
Cases Controls P value Cases Controls Crude OR P value
(n = 239) (n = 239) (n = 239) (n = 239) (95 % CI)
Age. Mean (SD) 5.4 ± 4.5 5.3 ± 4.6 0.48 Pneumonia in previous 2 years 23 (9.6 %) 8 (3.3 %) 3.23 (1.38 – 7.58) 0.007
Age group Asthma 27 (11.3 %) 13 (5.4 %) 2.45 (1.17 – 5.14) 0.02
0-4 134 (56.1 %) 135 (56.5 %) 0.29 Renal failure or nephritic
syndrome
4 (1.7 %) 2 (0.8 %) 2.00 (0.37 – 10.92) 0.42
5-17 205 (44.0 %) 104 (43.5 %) Diabetes 1 (0.4 %) 2 (0.8 %) 0.50 (0.04 – 5.51) 0.57
Female 101 (42.3 %) 108 (45.2 %) 0.49 Disabling neurological disease 8 (3.3 %) 3 (1.3 %) 2.67 (0.71 – 10.05) 0.15
Ethnicity Transplantation 4 (1.7 %) 1 (0.4 %) 4.00 (0.45 – 35.79) 0.21
White 209 (88.9 %) 218 (92.8 %) 0.56 Obesity 2 (1.1 %) 3 (1.6 %) 0.01 (0 – 1239.59) 0.44
Romany 9 (3.8 %) 5 (2.1 %) Previous antibiotics 31 (13.0 %) 41 (17.2 %) 0.67 (0.38 – 1.18) 0.16
Amerindian 7 (3.0 %) 6 (2.6 %) Systemic corticosteroids 10 (4.2 %) 4 (1.7 %) 3.20 (0.86 – 11.91) 0.08
Arab or North African 6 (2.6 %) 3 (1.3 %) Inhaled corticosteroids 21 (8.8 %) 13 (5.4 %) 1.73 (0.82 – 3.63) 0.15
Other 4 (1.7 %) 3 (1.3 %) ≥1 risk factors 47 (19.7 %) 32 (13.4 %) 1.67 (0.99 – 2.82) 0.05
Education level
parents
≥2 risk factors 7 (2.9 %) 3 (1.3 %) 2.52 (0.65 – 9.81) 0.18
Secondary or higher 168 (74.3 %) 160 (70.5 %) 0.35
Smoker parents 87 (36.6 %) 98 (41.4 %) 0.36
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in the spread of influenza epidemics [15–17]. This fact is
underscored by several studies which have proven the ef-
fects of school closures on influenza outbreaks suggesting
that school closure can reduce transmission of pandemic
and seasonal influenza among schoolchildren, although the
optimal school closure strategy is unclear [18].
Yet, although a large proportion of students may have
adequate knowledge on influenza, only some of themTable 2 Distribution of health information and non-pharmaceutical
Cases
(n = 239)
Received information on influenza prevention
No 56 (23.6 %)
Yes 181 (76.4 %) 1
Frequency of daily hand washing
1-4 times 123 (52.3 %) 1
>5 times 112 (47.7 %) 1
Use of alcohol-based hand sanitizers
Never 158 (67.2 %) 1
Sometimes 77 (32.8 %)
Hand washing after touching contaminated surfaces
Never 50 (21.4 %)
Sometimes 184 (78.6 %) 1
Influenza vaccine 2 (0.9 %)
Pneumococcal vaccine 79 (35.9 %)
aAdjusted for pneumonia in previous 2 years, asthma and disabling neurological dispractice preventive measures [19]. In our study we found
a negative association for influenza infection for both
washing more than 5 times per day and hand washing
after touching contaminated surfaces in the school age
group [5–17 years]. This fact stresses the importance of
health education in which parents and teachers play an
important role. No protective effect was observed in the
multivariate analysis for the use of alcohol-based hand
sanitizers. The use of masks could not be assessed duemeasures for confirmed outpatient cases and negative controls
Controls Crude OR P value Adjusted ORa P value
(n = 239) (95 % CI) (95 % CI)
51 (22.0 %) 1 1
81 (78.0 %) 0.83 (0.48 – 1.44) 0.51 0.72 (0.40 – 1.31) 0.29
07 (45.7 %) 1 1
27 (54.3 %) 0.69 (0.45 – 1.04) 0.07 0.62 (0.39 – 0.99) 0.04
70 (72.3 %) 1 1
65 (27.7 %) 1.36 (0.85 – 2.17) 0.21 1.54 (0.8 – 2.66) 0.13
43 (18.3 %) 1 1
92 (81.7 %) 0.73 (0.41 – 1.32) 0.30 0.62 (0.29 – 1.31) 0.21
5 (2.2 %) 0.44 (0.08 – 2.26) 0.32 0.27 (0.02 – 1.28) 0.09
69 (31.7 %) 1.52 (0.85 – 2.70) 0.15 1.47 (0.79 – 2.75) 0.22
ease
Table 3 Distribution of medical conditions for confirmed outpatient cases and negative controls according to age group
0-4 years 5-17 years
Cases Controls Crude OR P value Cases Controls Crude OR P value
(n = 122) (n = 122) (95 % CI) (n = 93) (n = 93) (95 % CI)
Pneumonia in previous 2 years 12 (9.8 %) 2 (1.6 %) 6.00 (1.34 – 26.81) 0.02 8 (8.6 %) 6 (6.5 %) 1.48 (0.47 – 4.70) 0.50
Asthma 10 (8.2 %) 4 (3.3 %) 3.00 (0.81 – 11.08) 0.10 16 (17.2 %) 9 (9.7 %) 2.07 (0.83 – 5.15) 0.12
Renal failure or nephritic
syndrome
1 (0.8 %) 0 (0.0 %) - - 3 (3.2 %) 2 (2.2 %) 1.50 (0.25 – 8.98) 0.66
Diabetes 0 (0.0 %) 0 (0.0 %) - - 1 (1.1 %) 2 (2.2 %) 0.50 (0.04 – 5.51) 0.57
Disabling neurological disease 1 (0.8 %) 3 (2.4 %) 0.33 (0.03 – 3.20) 0.34 6 (6.5 %) 0 (0.0 %) 65.29(0.09– 46313) 0.21
Transplantation 0 (0.0 %) 0 (0.0 %) - - 4 (4.3 %) 0 (0.0 %) 65.29 (0.02 – 202501.6) 0.31
Obesity 0 (0.0 %) 1 (1.1 %) - - 2 (2.6 %) 2 (2.6 %) 0.01 (0 – 500061.3) 0.58
Previous antibiotics 18 (14.8 %) 27 (22.0 %) 0.50 (0.22 – 1.11) 0.09 9 (9.7 %) 11 (11.8 %) 0.83 (0.33 – 2.11) 0.69
Systemic corticosteroids 4 (3.3 %) 1 (0.8 %) 4.00 (0.45 – 35.79) 0.21 5 (5.4 %) 2 (2.2 %) 4.70 (0.52 – 42.78) 0.17
Inhaled corticosteroids 13 (10.7 %) 7 (5.7 %) 2.20 (0.76 – 6.33) 0.14 7 (7.5 %) 5 (5.4 %) 1.40 (0.44 – 4.41) 0.57
≥1 risk factors 16 (13.1 %) 12 (9.8 %) 1.50 (0.61 – 3.67) 0.37 29 (31.2 %) 18 (19.4 %) 1.97 (0.97 – 3.96) 0.06
≥2 risk factors 1 (0.8 %) 2 (1.6 %) 0.50 (0.04 – 5.51) 0.57 6 (6.5 %) 1 (1.1 %) 6.77 (0.81 – 56.84) 0.08
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pediatric outpatient setting. Although there is limited
data to support the use of face masks and/or respirators
in healthcare and community settings, evidence suggests
that given the potential loss of effectiveness with incor-
rect usage, general advice should be to only use masks/
respirators under very particular, specified circum-
stances, and in combination with other personal pro-
tective practices [20]. Other studies in our setting
have found an adherence rate of < 50 %, and sug-
gested that facemasks are not useful in reducing sea-
sonal influenza infections in the community due to
their low acceptance, although they could be effective
in those who wore them [11].
Yet other authors find there is evidence to support the
use of masks and/or respirators in healthcare or com-
munity settings [21]. Mask use is best undertaken as part
of a package of personal protection, especially including
hand hygiene in both home and healthcare settings.
However, examination of the literature has shown
that most of the studies examined were too small to
reliably detect what would be anticipated to be mod-
erate effects [22].
Frequency of public transportation use was included
despite no recommendation was made by the Spanish
health authorities to avoid using public transportation
during the pandemic, because it can be considered a
mass gathering site and a source of infection
transmission.
In our study only 0.9 % of the children with underlying
chronic medical conditions, who were eligible for vac-
cination, had received any influenza vaccine, a fact that
was also observed by Altmann et al. They showed that93 % of these children, had not been vaccinated [23].
Low vaccination coverage among children aged <5 years
who are at greatest risk for influenza associated compli-
cations, and the low coverage among older children and
adolescents suggest that continued implementation of
existing strategies and the development of new strat-
egies to improve seasonal vaccination coverage are
needed [24]. The significant burden of influenza, on
children should encourage upgrading vaccination
coverage in these age groups and especially for those
included in risk groups for whom yearly vaccination
is recommended [25, 26].
As other authors have underscored, our data also
showed that clinical and epidemiological characteristics
of children infected with pandemic H1N1 2009 influenza
A versus those infected with post-pandemic/seasonal in-
fluenza AH1N1pmd09 [27, 28] bear no significant differ-
ences. For both seasons, significant differences were
shown for cases having presented with pneumonia in the
previous two years, asthma, inhaled corticosteroid treat-
ment and presenting with more than 1 co-morbidity.
There are several limitations to the study which have
to be considered, especially because of possible recall
bias with respect to report of hand-washing behavior
among cases and controls, although the questionnaires
were completed within few days from consultation.
There can also be a social desirability bias because of the
fact that people might say they do wash their hands or
use a hand sanitizer because that is what they are sup-
pose to do. This may carry a certain misclassification of
respondents which can not be accurately assessed.
Basic infection prevention interventions, including
hand hygiene [using soap and water or alcohol-based
Table 4 Distribution of health information and non-pharmaceutical measures for confirmed outpatient cases and negative controls according to age group
0-4 years 5-17 years
Cases Controls Crude OR Adjusted ORa P value Cases Controls Crude OR Adjusted ORb P value
(n = 122) (n = 122) (95 % CI) (95 % CI) (n = 93) (n = 93) (95 % CI) (95 % CI)
Received information on influenza prevention
No 37 (30.6 %) 32 (26.0 %) 1 1 15 (16.3 %) 14 (15.9 %) 1 1
Yes 84 (69.4 %) 91 (74.0 %) 0.71 (0.34-1.48) 0.74 (0.33 1.63) 0.45 77 (83.7 %) 74 (84.1 %) 0.83 (0.33 – 2.11) 0.72 (0.21 –2.50) 0.61
Frequency of daily hand washing
1-4 times 57 (48.3 %) 54 (45.0 %) 1 1 58 (62.4 %) 42 (46.2 %) 1 1
>5 times 61 (51.7 %) 66 (55.0 %) 0.80 (0.44- 1.47) 0.91 (0.46-1.78) 0.77 35 (37.6 %) 49 (53.8 %) 0.45 (0.23 – 0.87) 0.47 (0.22 – 0.99) 0.04
Use of alcohol-based hand sanitizers
Never 84 (71.2 %) 96 (79.3 %) 1 1 62 (66.7 %) 62 (68.1 %) 1 1
Sometimes 34 (28.8 %) 25 (20.7 %) 1.59 (0.85 -2.98) 1.45 (0.72 2.91) 0.29 31 (33.3 %) 29 (31.9 %) 1.09 (0.48 – 2.47) 1.29 (0.49 – 3.37) 0.60
Hand washing after touching contaminated surfaces
Never 22 (18.8 %) 26 (21.5 %) 1 1 26 (28.0 %) 16 (17.6 %) 1 1
Sometimes 95 (81.2 %) 95 (78.5 %) 1.36 (0.63-2.97) 1.06 (0.44-2.56) 0.90 67 (72.0 %) 75 (82.4 %) 0.27 (0.09 – 0.83) 0.19 (0.04 – 0.86) 0.03
a Adjusted for: pneumonia in previous 2 years and previous antibiotics. b Adjusted for: frequency of daily hand washing and hand washing after touching contaminated surface
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of respiratory viruses, particularly among young children
[29]. Stebbins et al. have shown that a respiratory hy-
giene intervention that included hand sanitizer use re-
duced school absences related to influenza A. Although
no significant effect of the intervention on the primary
study outcome of all laboratory-confirmed influenza
cases was found, there were statistically significant
differences in protocol-specified ancillary outcomes.
Children in intervention schools had significantly fewer
laboratory-confirmed influenza A infections than chil-
dren in control schools [30].
Allison et al. concluded that hand gel use is a feasible
strategy in settings were frequent hand washing might
not be possible, such as in elementary schools, and even
though acceptance of facemask use was low, most
teachers stated they would use masks in their classroom
in a pandemic [31]. Evidence from household, as well as
institutions, demonstrate that personal hygiene continue
to be a key prevention strategy against infection, thus it
is necessary to stress the importance of keeping proper
hygiene and cleaning practices to reduce the risk of
spreading infection [32].
Conclusion
The success of an NPI or a set of NPIs depends on both
its efficacy and the feasibility of implementing it with
relevant populations. If NPIs are to be used in commu-
nity settings during a severe influenza season or pan-
demic, to increase acceptability on the part of the adults
is of utmost importance. Without such acceptance, it is
highly unlikely that children and their supervising adults
will participate [33].
This study emphasizes the importance of simple infec-
tion prevention measures, such as hand hygiene which
have been proven effective to reduce the transmission of
infection in schools and the spread to household con-
tacts by Papenburg J,et al. [34]. Frequent hand washing
should be recommended to prevent influenza infection
in the family and community setting and in special in
the school age group.
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